Workers across Italy protest killing of trade union leader Adil Belakdhim
Adil Belakdhim was killed when a truck ran into a picket line of protesting logistics workers on June 18. Si Cobas, the union to which he belonged, has termed it the culmination of attacks on workers across the country
Cuba’s journey of developing vaccines while battling US blockade
Two new vaccines, both developed in Cuba, have shown remarkable efficacy in clinical trials. It is crucial to remember that Cuba developed these vaccines even as it continues to suffer under the crippling blockade imposed by the US.
Hundreds of more unmarked graves discovered in residential school in Canada
The Cowessess First Nation said that at least 600 unmarked graves have been discovered on the grounds of what used to be the Marieval Indian Residential School in Saskatchewan
Slow vaccination process dangerous, allows for rise of stronger variants
What is the new Delta variant? Is it more dangerous than earlier forms of the virus? Will old vaccines prove effective. Immunologist Dr. Satyajit Rath discusses these issues
Peace conference on Libya calls for immediate withdrawal of all foreign forces
The UN-sponsored second global Conference on Libya demanded that all foreign forces and mercenaries need to be withdrawn without delay. However, Turkey has raised objections to the call
Fatiha Briki is the latest Algerian human rights activist under detention
According to Fatiha Briki’s family and the National Committee for the Liberation of Detainees, of which she was a member, the activist was taken into custody on June 17. No reason has been provided by the authorities
Peruvians defend Pedro Castillo’s victory as Keiko Fujimori continues coup attempts
Right-wing Keiko Fujimori from Popular Force is still refusing to concede. Castillo won the elections with a margin of at least 44,000 votes.
Cuba’s Abdala and Soberana 02 vaccines near the finish line
The Abdala vaccine showed 92.28% efficacy with three doses during the third phase of clinical trials and the Soberana 02 vaccine showed 62% efficacy with just two of its three doses